Excess Alzheimer’s, related dementia-linked mortality increased during COVID-19
Jul 19, 2023
Among nursing home/long-term care residents, pandemic-era ADRD-related excess deaths decreased from 34,259 in year 1 to 22,050 in year 2, but excess deaths at home remained high (34,487 and 28,804, respectively).
Sleep-disordered breathing linked to medial temporal lobe atrophy in seniors
Jun 02, 2023
Higher sleep apnea severity was related to lower medial temporal lobe subregion volumes in amyloid-positive, but not amyloid-negative, individuals.
FDA gives full approval to Alzheimer’s disease drug Leqembi
Jul 06, 2023
Although Leqembi did help reduce mental decline compared with placebo, the drug has been linked to two deaths from brain bleeds.
FDA approves second drug for Alzheimer’s disease, despite safety concerns
Jan 06, 2023
The approval of lecanemab-irmb (Leqembi) comes after controversial approval in 2021 of aducanumab (Aduhelm), which met with criticism over concerns about that drug’s effectiveness, safety and pricing.
Omega-3 fatty acid concentration linked to cognitive function
Oct 05, 2022
In predominantly middle-aged cohort, higher omega-3 index linked to larger hippocampal volumes, better abstract reasoning
Adult survivors of childhood cancer may face late-onset memory impairment
Jun 02, 2023
The findings were seen decades after cancer diagnosis and treatment.
Postoperative cognitive issues common among middle-aged surgery patients
Oct 12, 2023
The researchers found that the 8-Item Informant Interview to Differentiate Aging and Dementia (AD8) abnormality incidence rates after noncardiac surgery increased from 2.2% at seven days to 17.1% at six...
Long-term study of postmenopausal women does not support many preventive therapies
May 02, 2024
Hormone therapy was no aid for cardiovascular disease prevention, and calcium/vitamin D supplementation was no aid for universal fracture prevention.